Analgesics Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Analgesics Market
Analgesics Market: By Type (Opioids, Non-Opioids) By Treatment Injection Route (Oral Injection, Intravenous Injection, Rectal Injection, Transdermal Injection, Topical Injection) & Geography-Forecast (2016-2021)
Report Code : HCR 0116
Published: 23 February, 2016   No. of pages: 142

  • Report Description
  • Table of Contents
  • Customization Options
An analgesic or painkiller is a drug which is used to achieve analgesia, relief from pain. This type of drugs are usually used when the pain is severe and becomes unbearable for the patient. This class of drugs provides relief from pain by either by blocking pain signals going to the brain or by interfering with the brain's interpretation of the signals, without producing anaesthesia or loss of consciousness. Analgesics are classified into three major categories namely simple analgesics, NSAIDS and Opioids. Some of the most commonly commercially available analgesics are paracetamol, aspirin, ibuprofen, naproxen sodium and many others

Globally demand for Analgesics market is driven by factors such as increasing instances of arthritis and acute chronic diseases and Growing R&D activities with emphasis on formulating new therapeutics for analgesics across the world.

This report identifies the Analgesics market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Analgesics market.

Analgesics Market

Globally North America dominated market for analgesics in 2015 and is estimated to continue the same during the period of study. Demand for analgesics in the region is estimated to be driven by analgesics related regulation coupled with new marketing strategies by analgesics companies. North American analgesics market is expected be followed by Europe and Asia-Pacific market respectively as the second and third largest analgesics market. Demand for analgesics market in Asia-Pacific is expected to grow due to higher willingness to self-medicate instead of visiting a trained physician for mild pain and fever is a trend that is common in a number of countries, more prominently in India.

In this report global Analgesics market is further segmented based on the basis of type, treatment injection route as follows:
  • Global Analgesics Market, By Type (2014-2021): Simple analgesics, Non steroidal anti inflammatory drugs (NSAIDS), and Opioids
  • Global Analgesics Market, By Treatment Injection Route (2014-2021): Oral Injection, Intravenous Injection, Rectal Injection, Transdermal Injection, and Topical Injection
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the global analgesics market. Some of the major companies’ profiles in detail are as follows:
  • GlaxoSmithKline
  • Pfizer Inc.
  • Novatis AG
  • Bayer Healthcare
  • Reckitt Benckiser (RB)
1. Analgesics – Market Overview
2. Executive Summary
Analgesics Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Analgesics – Market Forces
   4.1. Drivers
      4.1.1. Increasing instances of arthritis and acute chronic diseases
      4.1.2. Growing R&D activities with emphasis on formulating new therapeutics
   4.2. Restraints
      4.2.1. Side effects due to higher/regular doses
   4.3. Opportunities
      4.3.1. Changes in government policies of countries are increasing the preference for OTC drugs over prescription drugs
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Analgesics Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Analgesics Market - By Type
   6.1. Simple analgesics
   6.2. Non steroidal anti inflammatory drugs (NSAIDS)
   6.3. Opioids
7. Global Analgesics Market - By Treatment Injection Route 
   7.1. Oral Injection
   7.2. Intravenous Injection
   7.3. Rectal Injection
   7.4. Transdermal Injection
   7.5. Topical Injection
8. Global Analgesics Market - By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Analgesics – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. GlaxoSmithKline
      10.1.1. Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Pfizer Inc.
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. Novatis AG
      10.3.1.  Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. Bayer Healthcare
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. Reckitt Benckiser (RB)
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. Bristol-Myers Squibb
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Endo Pharmaceuticals
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Sanofi
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. Purdue Pharma
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Johnson & Johnson
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports